Hypersensitivity Pneumonitis clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for

  • FAPI PET for Lung Fibrosis

    open to eligible people ages 18 years and up

    This is a prospective exploratory biodistribution study in patients with interstitial lung disease (ILD). The purpose of this research study is to determine where and to which degree the FAPI tracer (68Ga-FAPI-46) accumulates in normal and fibrotic…

    at UCLA

  • Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis

    open to eligible people ages 18-85

    Up to 135 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.

    at UC Davis

Our lead scientists for Hypersensitivity Pneumonitis research studies include .

Last updated: